Chief Legal Officer

Management Team

John R. Martin, J.D.

Corporate attorney with over 20 years experience

news

May 19
Adial Pharmaceuticals Announces Research Collaboration with the Medical College of Wisconsin to Advance Purnovate’s Adenosine Compounds as Potential Treatments for Diabetes and NASH
Continue Reading
May 16
Adial Pharmaceuticals Provides Business Update and Reports First Quarter 2022 Financial Results
Continue Reading
May 4
Adial Pharmaceuticals Announces Research Collaboration with UC San Diego to Advance Purnovate’s Adenosine Compounds as Potential Treatments for Inflammatory Diseases & Disorders
Continue Reading
March 22
Adial Pharmaceuticals CEO to Participate in a Fireside Chat at the 2022 Virtual Growth Conference Presented by Maxim Group LLC and hosted by M-Vest on March 28th
Continue Reading
February 24
Adial Pharmaceuticals Announces Completion of Last Patient, Last Visit in its ONWARD™ Phase 3 Trial of AD04 for the Treatment of Patients with Alcohol Use Disorder
Continue Reading

Adial Overview 2020
Watch Now
Adial Overview
Watch Now
About the growing AUD market and Adial's targeted potential treatment
Watch Now
NBC29: UVA Researchers & Adial looking into using Purnovate in Burn Wound Care
Watch Now
CEO Bill Stilley talks about AD04 on CBS46 Atlanta
Watch Now
Newsy Morning Rush with Bill Stilley discussing AUD & AD04
Watch Now